scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1039123149 |
P356 | DOI | 10.1007/S00253-015-6952-Z |
P698 | PubMed publication ID | 26373723 |
P5875 | ResearchGate publication ID | 282042494 |
P50 | author | S.a Rahim Rezaee | Q42862657 |
Kiarash Ghazvini | Q57794555 | ||
Hadi Farsiani | Q86166322 | ||
Arman Mosavat | Q86166324 | ||
P2093 | author name string | Mojtaba Sankian | |
Saman Soleimanpour | |||
Zahra Meshkat | |||
Hamid Sadeghian | |||
Mohammad Reza Akbari Eydgahi | |||
P2860 | cites work | The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools | Q24248165 |
Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics | Q26822421 | ||
Vaccines against tuberculosis: where are we and where do we need to go? | Q26992233 | ||
Structure validation by Calpha geometry: phi,psi and Cbeta deviation | Q27860657 | ||
Verification of protein structures: patterns of nonbonded atomic interactions | Q29615613 | ||
T-bet is rapidly induced by interferon-gamma in lymphoid and myeloid cells | Q33952975 | ||
ESAT-6 proteins: protective antigens and virulence factors? | Q33982392 | ||
IL-17 and Th17 cells in tuberculosis | Q34545889 | ||
Ebola virus glycoprotein Fc fusion protein confers protection against lethal challenge in vaccinated mice | Q34761889 | ||
Subunit vaccine consisting of multi-stage antigens has high protective efficacy against Mycobacterium tuberculosis infection in mice | Q34965575 | ||
Neonatal Fc receptor for IgG (FcRn) regulates cross-presentation of IgG immune complexes by CD8-CD11b+ dendritic cells | Q35049100 | ||
An epigenetic view of helper T cell differentiation | Q35164202 | ||
A neonatal Fc receptor-targeted mucosal vaccine strategy effectively induces HIV-1 antigen-specific immunity to genital infection | Q35274924 | ||
Polymeric human Fc-fusion proteins with modified effector functions | Q35551564 | ||
HspX-mediated protection against tuberculosis depends on its chaperoning of a mycobacterial molecule | Q36439241 | ||
Impact of IgA constant domain on HIV-1 neutralizing function of monoclonal antibody F425A1g8. | Q36487349 | ||
Epigenetic control of T-helper-cell differentiation | Q37371624 | ||
Cytokine therapy of tuberculosis at the crossroads | Q37754962 | ||
Immunotherapy for tuberculosis: what's the better choice? | Q38015155 | ||
Fc-fusion proteins: new developments and future perspectives. | Q38029985 | ||
Vaccination against tuberculosis: how can we better BCG? | Q38068986 | ||
The immune response in tuberculosis | Q38091698 | ||
Harnessing local and systemic immunity for vaccines against tuberculosis | Q38164196 | ||
Fc fusion as a platform technology: potential for modulating immunogenicity | Q38285478 | ||
Adjuvant-free immunization with hemagglutinin-Fc fusion proteins as an approach to influenza vaccines | Q39614628 | ||
T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis. | Q40076818 | ||
Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine | Q40296230 | ||
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns | Q41775340 | ||
Plant-derived recombinant immune complexes as self-adjuvanting TB immunogens for mucosal boosting of BCG. | Q44512209 | ||
Role of T-bet in commitment of TH1 cells before IL-12-dependent selection. | Q51065721 | ||
IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge | Q58518610 | ||
P433 | issue | 24 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 10467-10480 | |
P577 | publication date | 2015-09-15 | |
P1433 | published in | Applied Microbiology and Biotechnology | Q13553694 |
P1476 | title | APC targeting enhances immunogenicity of a novel multistage Fc-fusion tuberculosis vaccine in mice | |
P478 | volume | 99 |